WO2021046741A1 - Substrate material for high-efficiency surface-enhanced raman scattering and preparation method - Google Patents
Substrate material for high-efficiency surface-enhanced raman scattering and preparation method Download PDFInfo
- Publication number
- WO2021046741A1 WO2021046741A1 PCT/CN2019/105288 CN2019105288W WO2021046741A1 WO 2021046741 A1 WO2021046741 A1 WO 2021046741A1 CN 2019105288 W CN2019105288 W CN 2019105288W WO 2021046741 A1 WO2021046741 A1 WO 2021046741A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- solution
- stirring
- gold
- enhanced raman
- volume ratio
- Prior art date
Links
- 239000000463 material Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 239000000758 substrate Substances 0.000 title claims abstract description 29
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 title claims description 33
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 86
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 59
- 238000001069 Raman spectroscopy Methods 0.000 claims abstract description 25
- RYWSYCQQUDFMAU-UHFFFAOYSA-N Acetomenaphthone Chemical compound C1=CC=C2C(OC(=O)C)=CC(C)=C(OC(C)=O)C2=C1 RYWSYCQQUDFMAU-UHFFFAOYSA-N 0.000 claims abstract description 24
- 238000001514 detection method Methods 0.000 claims abstract description 21
- 239000002078 nanoshell Substances 0.000 claims abstract description 19
- 239000000243 solution Substances 0.000 claims description 253
- 229910052709 silver Inorganic materials 0.000 claims description 58
- 239000004332 silver Substances 0.000 claims description 58
- 238000003756 stirring Methods 0.000 claims description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 53
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 50
- 239000002073 nanorod Substances 0.000 claims description 46
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 42
- 239000002244 precipitate Substances 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 25
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 25
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 claims description 22
- 238000003760 magnetic stirring Methods 0.000 claims description 22
- 229960005070 ascorbic acid Drugs 0.000 claims description 21
- 235000010323 ascorbic acid Nutrition 0.000 claims description 21
- 239000011668 ascorbic acid Substances 0.000 claims description 21
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 20
- 239000008367 deionised water Substances 0.000 claims description 19
- 229910021641 deionized water Inorganic materials 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000000725 suspension Substances 0.000 claims description 17
- 239000003085 diluting agent Substances 0.000 claims description 16
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 12
- 230000006378 damage Effects 0.000 claims description 10
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 claims description 9
- 230000008859 change Effects 0.000 claims description 8
- 238000009210 therapy by ultrasound Methods 0.000 claims description 8
- 238000006193 diazotization reaction Methods 0.000 claims description 7
- 238000005119 centrifugation Methods 0.000 claims description 5
- 206010061481 Renal injury Diseases 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 238000010790 dilution Methods 0.000 claims description 4
- 239000012895 dilution Substances 0.000 claims description 4
- 208000037806 kidney injury Diseases 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 3
- 108090000288 Glycoproteins Proteins 0.000 claims description 2
- 102000003886 Glycoproteins Human genes 0.000 claims description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- 239000006185 dispersion Substances 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- 238000004321 preservation Methods 0.000 claims description 2
- 150000003717 vitamin K4 derivatives Chemical group 0.000 claims description 2
- 102100034459 Hepatitis A virus cellular receptor 1 Human genes 0.000 abstract description 18
- 210000002700 urine Anatomy 0.000 abstract description 15
- 101710185991 Hepatitis A virus cellular receptor 1 homolog Proteins 0.000 abstract description 10
- 238000005516 engineering process Methods 0.000 abstract description 10
- 230000035945 sensitivity Effects 0.000 abstract description 9
- 239000000523 sample Substances 0.000 abstract 1
- 101001068136 Homo sapiens Hepatitis A virus cellular receptor 1 Proteins 0.000 description 8
- 239000011521 glass Substances 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 230000003068 static effect Effects 0.000 description 5
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000002923 metal particle Substances 0.000 description 4
- 239000002356 single layer Substances 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 239000000090 biomarker Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 208000030090 Acute Disease Diseases 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 238000001237 Raman spectrum Methods 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 208000020832 chronic kidney disease Diseases 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000004627 transmission electron microscopy Methods 0.000 description 2
- 108010055851 Acetylglucosaminidase Proteins 0.000 description 1
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229910004042 HAuCl4 Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102100030122 Protein O-GlcNAcase Human genes 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 201000011040 acute kidney failure Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229960003151 mercaptamine Drugs 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000007079 thiolysis reaction Methods 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/65—Raman scattering
Definitions
- the invention relates to the technical field of Raman scattering, in particular to a high-efficiency surface-enhanced Raman scattering base material and a preparation method.
- kidney damage characterized by kidney damage is one of the most challenging health problems worldwide.
- urine routine tests, osmotic pressure, blood creatinine, urea nitrogen, and endogenous creatinine clearance are generally used to determine kidney damage.
- NAG enzyme N-acetyl- ⁇ -D-glucosaminidase
- KIM-1 kidney injury molecule 1
- the content of -1 can change within 4-6 hours after kidney injury. It can quickly, sensitively and specifically reflect the damage and recovery process of various kidney diseases. It can become a reliable biological marker for detecting early kidney injury. Therefore, High-precision detection of KIM-1 content in urine is of great significance for the diagnosis and treatment of acute and chronic kidney diseases characterized by kidney damage.
- the main method for determining the KIM-1 content in urine is the ELISA method with a sensitivity of pg/ml. Therefore, this method cannot achieve the quantitative detection of KIM-1 content in urine within a large dynamic range.
- SERS Surface Enhanced Raman Scattering
- SERS detection can be completed quickly within a few minutes. Therefore, surface-enhanced Raman scattering has been widely used in various chemical sensing, biological analysis, biosensing, and early cancer diagnosis.
- the current surface-enhanced Raman scattering substrate materials mostly use smooth macroscopic glass, gold, and silver. Or the bimetal film as the base material does not have sufficient plasma "hot spots", which leads to the limited sensitivity of the surface enhanced Raman technology.
- the current selection of SERS detection substrate material is used to bond Manra detection molecules, of which the best effect is the P-ATP molecule, the sensitivity is ng/ml-pg/ml, although the P-ATP is bonded After the molecule, the sensitivity of SERS detection has been improved, but the detection sensitivity and detection range width required by many detected objects are higher.
- the purpose of the present invention is to provide an efficient surface-enhanced Raman scattering substrate material and a preparation method, which can achieve high-sensitivity detection of KIM-1 content in urine, up to fg/ml level, thereby achieving a KIM-1 with a large dynamic range Assay.
- One aspect of the present invention is to provide a high-efficiency surface-enhanced Raman scattering substrate including:
- Nano-shell the nano-shell is made of nano-silver material, the nano-shell is evenly and completely wrapped on the surface of the nano-core, and the outer surface of the nano-shell is bonded with the Raman detection molecule vitamin K4.
- the vitamin K4 introduces a sulfhydryl group through diazotization thiolysis.
- the diameter of the nano-core is 19-26 nm, and the length is 80-96 nm.
- the thickness of the nano-shell is 2-18 nm.
- Another aspect of the present invention is to provide a method for preparing a high-efficiency surface-enhanced Raman scattering base material, which includes the following steps:
- the vitamin K4 ethanol solution is diazotized and mercaptolyzed to introduce sulfhydryl groups, and then added to the gold core silver shell nanorod suspension to obtain a mixture, and the mixture is gently shaken to obtain vitamin K4 labeled gold core silver shell nanorods.
- step 1) is deionized water
- the concentration of the HAuCl 4 solution is 25 mM, and the dilution factor is 50 times;
- the concentration of the CTAB solution is 0.2M
- the volume ratio of the HAuCl 4 solution to the CTAB solution is 1:50;
- step 2) the concentration of the NaBH 4 solution is 0.01M, the temperature is 25-30°C, and it is ready to use;
- the volume ratio of the NaBH 4 solution to the HAuCl 4 solution is 1:6;
- the stirring in step 2) is magnetic stirring, the speed of the magnetic stirring is 1200rpm, the time is 2min, the standing time is 30min, and the temperature is 25-30°C;
- step 3 the dissolving temperature is 50°C, and the cooling temperature is 28-30°C;
- the volume ratio of the water in step 3) to the NaBH 4 solution in step 2) is 1250:3;
- the volume ratio of CTAB, the mass of sodium oleate and the volume of silver nitrate solution in step 3) to the HAuCl4 solution in step 1) is 70g: 12.34g: 180ml: 1ml;
- the concentration of the silver nitrate solution is 4.0 M, and the holding time is 1 min;
- the concentration of the HAuCl 4 solution is 1.0 mM, the concentration of the HCl solution is 37 wt%, and the concentration of the ascorbic acid solution is 0.064 M;
- the volume ratio of the HAuCl 4 solution, the HCl solution and the ascorbic acid solution in step 4) to the water in step 3) is 250:2.1:1.25:250;
- the first stirring in step 4) is magnetic stirring, the speed is 700 rpm, and the duration is 90 min;
- the second stirring in step 4) is magnetic stirring, the speed is 400rpm, and the duration is 15min;
- the third stirring in step 4) is magnetic stirring, the speed is 1200rpm, and the duration is 30s;
- the volume ratio of the added amount of the seed solution in step 5) to the HAuCl 4 solution in step 1) is 4:1;
- the stirring in step 5) is magnetic stirring, the speed is 1500rpm, and the duration is 30s;
- step 5 the standing temperature is 28-30°C, and the time is 8-12h;
- the speed of centrifugation mentioned in step 5 is 8000r/min, and the duration is 10min
- step 5 the concentration of the CTAC solution is 80 mM, and the volume ratio of the CTAC solution to the seed solution is 1:2;
- step 6 the concentration of the CTAC solution is 80 mM, and the volume ratio of the CTAC solution to the seed solution is 1:2;
- step 2 the water in step 2 is deionized water, and the dilution factor is 8 times;
- the concentration of the nitric acid solution is 10 mM, and the volume ratio of the silver nitrate solution to the gold nanorod solution is (1:0.4)-(1:5);
- the volume ratio of the ascorbic acid solution to the silver nitrate solution is 1:1;
- the frequency of the ultrasonic treatment is 100KHz, and the treatment time is 2min;
- the storage temperature in the water bath is 63-68°C, and the time is 4h;
- the rotation speed of the centrifugation is 8000r/min, and the time is 10min;
- the solution used for the dispersion is deionized water, and the volume ratio of the deionized water to the gold nanorod solution is 1:2.
- step 3 the volume ratio of the vitamin K4 ethanol solution to the gold core silver shell nanorod suspension is 1:500;
- the gentle shaking time is 2h.
- the invention also provides the use of the high-efficiency surface-enhanced Raman scattering base material in preparing the surface-enhanced Raman scattering base material for detecting kidney damage factors.
- kidney injury factor is a glycoprotein immune substance.
- the high-efficiency surface-enhanced Raman scattering substrate material provided by the present invention no longer uses the macroscopic materials widely cited in the prior art, but chooses nano-scale metal particles.
- the local electromagnetic field of the nano-scale metal particles can be significantly enhanced, which is different from the traditional gold Compared with nanoparticles, gold-core-silver-shell nanoparticles can further enhance electromagnetic signals.
- vitamin K4 is bonded to the surface of the gold-core-silver shell, so that the electromagnetic coupling between two nano-metal particles at the junction of two nano-metal particles can produce up to
- the SERS enhancement factor (EF) of 10 14 can greatly enhance the detection sensitivity.
- the invention also provides a method for preparing a highly efficient surface-enhanced Raman scattering substrate material.
- the preparation method can well adjust the thickness of the silver shell by controlling the concentration of silver nitrate and ascorbic acid in the silver shell growth solution. Thickness of the silver shell.
- Figure 1A is a transmission electron microscopy image of gold nanorods
- Figure 1B- Figure 1F are transmission electron microscopy images of gold core-silver shell nanorods with silver shells of different thicknesses prepared in 0.2, 0.5, 1.0, 2.0 and 2.5 mL silver nitrate solutions;
- Figure 2 shows the UV-NIR extinction spectra of gold nanorods and silver shells of different thicknesses prepared in 0.2, 0.5, 1.0, 2.0 and 2.5 mL silver nitrate solutions;
- Figure 4 is a graph of the Raman intensity varying with the thickness of the silver shell at a spectrum of 1080 cm -1;
- Figure 5 shows the high-sensitivity recognition ability of low-concentration KIM-1 in human urine based on the single-layer array film of gold-core-silver-shell nanorods;
- Figure 6 shows that the SERS intensity has a biomarker concentration at 1145 cm -1 , and the inset shows its wide dynamic detection range.
- This embodiment provides a substrate material based on surface-enhanced Raman technology and a preparation method thereof, and the structure of the substrate material is:
- Gold nanorod core with a diameter of 23nm and a length of 89.2nm;
- the gold core silver shell nanorod is prepared by the following preparation method, and the preparation method includes the following steps:
- step 6) Repeat step 5) three times, and store the precipitate in CTAC solution to obtain a gold nanorod solution;
- This embodiment provides a substrate material based on surface-enhanced Raman technology and a preparation method thereof, and the structure of the substrate material is:
- the core of gold nanorods has a diameter of 21.7 and a length of 93.8;
- the gold core silver shell nanorod is prepared by the following preparation method, and the preparation method includes the following steps:
- step 6) Repeat step 5) three times, and store the precipitate in the CTAC solution to obtain the gold nanorod solution.
- This embodiment provides a substrate material based on surface-enhanced Raman technology and a preparation method thereof, and the structure of the substrate material is:
- the core of gold nanorods has a diameter of 24.3nm and a length of 84.6nm;
- the gold core silver shell nanorod is prepared by the following preparation method, and the preparation method includes the following steps:
- step 6) Repeat step 5) three times, and store the precipitate in the CTAC solution to obtain the gold nanorod solution.
- This embodiment provides a substrate material based on surface-enhanced Raman technology and a preparation method thereof, and the structure of the substrate material is:
- the core of gold nanorods has a diameter of 22.8nm and a length of 90.4nm;
- the gold core silver shell nanorod is prepared by the following preparation method, and the preparation method includes the following steps:
- step 6) Repeat step 5) three times, and store the precipitate in the CTAC solution to obtain the gold nanorod solution.
- This embodiment provides a substrate material based on surface-enhanced Raman technology and a preparation method thereof, and the structure of the substrate material is:
- the core of gold nanorods has a diameter of 24.0nm and a length of 91.5nm;
- the gold core silver shell nanorod is prepared by the following preparation method, and the preparation method includes the following steps:
- step 6) Repeat step 5) three times, and store the precipitate in the CTAC solution to obtain the gold nanorod solution.
- the single-layer array films of gold core silver shell nanorods and gold nanorods in Examples 1-5 were respectively produced:
- the SERS intensity is the best when the diameter of the gold nanorod is 22nm, the length is 90nm, and the thickness of the silver nanoshell is 16nm, which can reach 100 times that of the gold nanorod as the base material.
- the vitamin K4 labeled gold core silver shell nanorods of the present invention replace the base material in the traditional SERS, and are used for the analysis of standard KIM1 biomarkers in artificial urine.
- the gold core silver shell nanorod solution was functionalized with 150 mM cysteamine solution. Then, 12 ⁇ L of 25% wt glutaraldehyde solution was added to functionalize the gold core silver shell nanorod solution. Add 12mL of 20 ⁇ g/mL KIM1 capture antibody solution to the transformed gold core silver shell nanorod solution and store it at 4°C for 12 hours. Next, add 12mL of 1% BSA solution to the stored solution and let it stand for 1 hour. In order to block non-specific binding to the active site, a substrate structure solution is obtained.
- the substrate solution was equally divided into 6 parts, and 6 kinds of urine to be tested were added to the 6 parts of substrate solution respectively, and incubated at room temperature for 1 hour to obtain the KIM1 urine to be tested.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Composite Materials (AREA)
- Molecular Biology (AREA)
- Manufacturing & Machinery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
Description
Claims (10)
- 一种高效表面增强拉曼散射基底材料,包括:An efficient surface-enhanced Raman scattering substrate material, including:纳米内核,所述纳米内核是由金纳米棒构成;和A nano-core, the nano-core is composed of gold nanorods; and纳米外壳,所述纳米外壳是由纳米银材料构成,所述纳米外壳均匀完全的包裹于所述纳米内核表面,所述纳米外壳外表面结合有拉曼检测分子。Nano-shell, the nano-shell is made of nano-silver material, the nano-shell is evenly and completely wrapped on the surface of the nano-core, and the outer surface of the nano-shell is bound with Raman detection molecules.
- 根据权利要求1所述的表面增强拉曼散射基底材料,其特征在于,所述拉曼检测分子为维生素K4,所述维生素K4经重氮化巯解引入巯基。The surface-enhanced Raman scattering substrate material of claim 1, wherein the Raman detection molecule is vitamin K4, and the vitamin K4 introduces a sulfhydryl group through diazotization and sulfhydrylation.
- 根据权利要求1所述的表面增强拉曼散射基底材料,其特征在于,所述纳米内核的直径为19-26nm,长度为80-96nm。The surface-enhanced Raman scattering substrate material of claim 1, wherein the nano-core has a diameter of 19-26 nm and a length of 80-96 nm.
- 根据权利要求1所述的表面增强拉曼散射基底材料,其特征在于,所述纳米外壳的厚度为2-18nm。The surface-enhanced Raman scattering base material of claim 1, wherein the thickness of the nano-shell is 2-18 nm.
- 一种权利要求1-4所述的高效表面增强拉曼散射基底材料的制备方法,其特征在于,包括以下步骤:A method for preparing a high-efficiency surface-enhanced Raman scattering base material according to claims 1-4, characterized in that it comprises the following steps:(1)金纳米棒的制备;(1) Preparation of gold nanorods;1)用水对HAuCl 4溶液进行稀释得到稀释液,向稀释液中的加入CTAB溶液得到溶液一; 1) Dilute the HAuCl 4 solution with water to obtain a diluent, and add CTAB solution to the diluent to obtain solution one;2)将溶液一快速注入NaBH 4溶液中,搅拌得到种子溶液,静置; 2) Quickly inject the solution into the NaBH 4 solution, stir to obtain the seed solution, and let it stand;3)将CTAB和油酸钠溶解于水中,冷却后加入硝酸银溶液,保温后得到溶液二;3) Dissolve CTAB and sodium oleate in water, add silver nitrate solution after cooling, and obtain solution 2 after heat preservation;4)一边搅拌一边向溶液二中注射HAuCl 4溶液,继续第一次搅拌,改变第二次搅拌速度,一边搅拌一边加入HCl溶液,继续第二次搅拌,最后加入抗坏血酸溶液,进行第三次搅拌,得到生长液; 4) While stirring, inject the HAuCl 4 solution into the second solution, continue the first stirring, change the second stirring speed, add the HCl solution while stirring, continue the second stirring, and finally add the ascorbic acid solution, and perform the third stirring , Get the growth solution;5)将种子溶液注入生长液中得到混合溶液,将混合溶液静置,将静置后的混合溶液进行离心,收集沉淀物,将沉淀物分散于CTAC溶液中;5) Inject the seed solution into the growth solution to obtain a mixed solution, leave the mixed solution to stand, centrifuge the settled mixed solution, collect the precipitate, and disperse the precipitate in the CTAC solution;6)将步骤5)重复三次,将所述得沉淀物储存在CTAC溶液中,得到金纳米棒溶液;6) Repeat step 5) three times, and store the precipitate in CTAC solution to obtain a gold nanorod solution;(2)金核银壳纳米棒的制备;(2) Preparation of gold core silver shell nanorods;将金纳米棒溶液用水稀释,向稀释液中加入硝酸银溶液,进行超声波处理后加入抗坏血酸溶液,经水浴保存、离心和分散得到金核银壳纳米棒悬浮液;Dilute the gold nanorod solution with water, add silver nitrate solution to the diluent, add ascorbic acid solution after ultrasonic treatment, store in a water bath, centrifuge and disperse to obtain a gold core silver shell nanorod suspension;(3)拉曼检测分子的键合;(3) Raman detects the bonding of molecules;将维生素K4乙醇溶液经重氮化巯解引入巯基,再添加到金核银壳纳米棒悬浮液中得到混合物,温和摇动混合物,得到拉维生素K4标记的金核银壳纳米棒。The vitamin K4 ethanol solution is diazotized and mercaptolyzed to introduce sulfhydryl groups, and then added to the gold core silver shell nanorod suspension to obtain a mixture, and the mixture is gently shaken to obtain vitamin K4 labeled gold core silver shell nanorods.
- 根据权利要求5所述的一种高效表面增强拉曼散射基底材料制备方法,其特征在于,步骤1)中所述水为去离子水;The method for preparing a high-efficiency surface-enhanced Raman scattering base material according to claim 5, wherein the water in step 1) is deionized water;所述HAuCl 4溶液的浓度为25mM,所述稀释的倍数为50倍; The concentration of the HAuCl 4 solution is 25 mM, and the dilution factor is 50 times;所述CTAB溶液的浓度为0.2M;The concentration of the CTAB solution is 0.2M;所述HAuCl 4溶液与所述CTAB溶液的体积比为1:50; The volume ratio of the HAuCl 4 solution to the CTAB solution is 1:50;步骤2)中所述NaBH 4溶液的浓度为0.01M,现用现配; The concentration of the NaBH 4 solution in step 2) is 0.01M, and it is ready to use;所述NaBH 4溶液与所述HAuCl 4溶液的体积比为1:6; The volume ratio of the NaBH 4 solution to the HAuCl 4 solution is 1:6;步骤2)中所述搅拌为磁力搅拌,所述磁力搅拌的速度为1200rpm,时间为2min,所述静置时间为30min,温度为25-30℃;The stirring in step 2) is magnetic stirring, the speed of the magnetic stirring is 1200rpm, the time is 2min, the standing time is 30min, and the temperature is 25-30°C;步骤3)中所述溶解温度为50℃,所述冷却温度为28-30℃;In step 3), the dissolving temperature is 50°C, and the cooling temperature is 28-30°C;步骤3)中所述水与步骤2)中所述NaBH 4溶液的体积比为1250:3; The volume ratio of the water in step 3) to the NaBH 4 solution in step 2) is 1250:3;步骤3)中所述CTAB、油酸钠质量和硝酸银溶液体积与步骤1)中所述HAuCl 4溶液的体积比为70g:12.34g:180ml:1ml; The volume ratio of CTAB, the mass of sodium oleate and the volume of silver nitrate solution in step 3) to the HAuCl 4 solution in step 1) is 70g: 12.34g: 180ml: 1ml;所述硝酸银溶液得浓度为4.0M,所述保温的时间为1min;The concentration of the silver nitrate solution is 4.0 M, and the holding time is 1 min;步骤4)中所述HAuCl 4溶液的浓度为1.0mM,所述HCl溶液的浓度 为37wt%,所述抗坏血酸溶液得浓度为0.064M; In step 4), the concentration of the HAuCl 4 solution is 1.0 mM, the concentration of the HCl solution is 37 wt%, and the concentration of the ascorbic acid solution is 0.064 M;步骤4)中所述HAuCl 4溶液、HCl溶液和所述抗坏血酸溶液与步骤3)中所述水的体积比为250:2.1:1.25:250; The volume ratio of the HAuCl 4 solution, the HCl solution and the ascorbic acid solution in step 4) to the water in step 3) is 250:2.1:1.25:250;步骤4)中所述第一次搅拌为磁力搅拌,速度为700rpm,持续时间为90min;The first stirring in step 4) is magnetic stirring, the speed is 700 rpm, and the duration is 90 min;步骤4)中所述第二次搅拌为磁力搅拌,速度为400rpm,持续时间为15min;The second stirring in step 4) is magnetic stirring, the speed is 400rpm, and the duration is 15min;步骤4)中所述第三次搅拌为磁力搅拌,速度为1200rpm,持续时间为30s;The third stirring in step 4) is magnetic stirring, the speed is 1200rpm, and the duration is 30s;步骤5)中所述种子溶液的加入量与步骤1)中所述HAuCl 4溶液的体积比为4:1; The volume ratio of the added amount of the seed solution in step 5) to the HAuCl 4 solution in step 1) is 4:1;步骤5)中所述搅拌为磁力搅拌,速度为1500rpm,持续时间为30s;The stirring in step 5) is magnetic stirring, the speed is 1500rpm, and the duration is 30s;步骤5)中所述静置的温度为25-30℃,时间为8-12h;In step 5), the standing temperature is 25-30°C, and the time is 8-12h;步骤5)中所述离心的转速为8000r/min,持续时间为10minThe speed of centrifugation mentioned in step 5) is 8000r/min, and the duration is 10min步骤5)中所述CTAC溶液的浓度为80mM,所述CTAC溶液与所述种子溶液的体积比为1:2;In step 5), the concentration of the CTAC solution is 80 mM, and the volume ratio of the CTAC solution to the seed solution is 1:2;步骤6)中所述CTAC溶液的浓度为80mM,所述CTAC溶液与所述种子溶液的体积比为1:2;In step 6), the concentration of the CTAC solution is 80 mM, and the volume ratio of the CTAC solution to the seed solution is 1:2;
- 根据权利要求5所述的一种高效表面增强拉曼散射基底材料制备方法,其特征在于,步骤2中所述水为去离子水,所述稀释的倍数为8倍;The method for preparing a high-efficiency surface-enhanced Raman scattering base material according to claim 5, wherein the water in step 2 is deionized water, and the dilution factor is 8 times;所述硝酸溶液的浓度为10mM,所述硝酸银溶液与所述金纳米棒溶液的体积比为(1:0.4)-(1:5);The concentration of the nitric acid solution is 10 mM, and the volume ratio of the silver nitrate solution to the gold nanorod solution is (1:0.4)-(1:5);所述抗坏血酸溶液的体积与所述硝酸银溶液的体积比为1:1;The volume ratio of the ascorbic acid solution to the silver nitrate solution is 1:1;所述超声波处理的频率为100kHz,处理时间为2min;The frequency of the ultrasonic treatment is 100kHz, and the treatment time is 2min;所述水浴保存的温度为63-68℃,时间为4h;The storage temperature in the water bath is 63-68°C, and the time is 4h;所述离心的转速为8000r/min,时间为10min;The rotation speed of the centrifugation is 8000r/min, and the time is 10min;所述分散所用的溶液为去离子水,所述去离子水与所述金纳米棒溶液体积比为1:2.The solution used for the dispersion is deionized water, and the volume ratio of the deionized water to the gold nanorod solution is 1:2.
- 根据权利要求5所述的一种高效表面增强拉曼散射基底材料制备方法,其特征在于,步骤3中所述维生素K4乙醇溶液与所述金核银壳纳米棒悬浊液的体积比为1:500;The method for preparing a high-efficiency surface-enhanced Raman scattering substrate material according to claim 5, wherein the volume ratio of the vitamin K4 ethanol solution to the gold core silver shell nanorod suspension in step 3 is 1 :500;所述温和摇动的时间为2h。The gentle shaking time is 2h.
- 权利要求1-4任一项所述的高效表面增强拉曼散射基底材料在制备检测肾损伤因子的表面增强拉曼散射基底材料中的用途。Use of the high-efficiency surface-enhanced Raman scattering substrate material of any one of claims 1 to 4 in preparing a surface-enhanced Raman scattering substrate material for detecting renal damage factors.
- 根据权利要求9所述的用途,其特征在于,所述肾损伤因子为糖蛋白类免疫物质。The use according to claim 9, wherein the kidney injury factor is a glycoprotein immune substance.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2019/105288 WO2021046741A1 (en) | 2019-09-11 | 2019-09-11 | Substrate material for high-efficiency surface-enhanced raman scattering and preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2019/105288 WO2021046741A1 (en) | 2019-09-11 | 2019-09-11 | Substrate material for high-efficiency surface-enhanced raman scattering and preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021046741A1 true WO2021046741A1 (en) | 2021-03-18 |
Family
ID=74865942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2019/105288 WO2021046741A1 (en) | 2019-09-11 | 2019-09-11 | Substrate material for high-efficiency surface-enhanced raman scattering and preparation method |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2021046741A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103257133A (en) * | 2013-04-18 | 2013-08-21 | 上海交通大学 | Preparation method and application of mercury ion detection probe |
US20140234219A1 (en) * | 2013-02-15 | 2014-08-21 | Panasonic Corporation | Method and Device for Detecting Analytes |
CN104458694A (en) * | 2014-11-28 | 2015-03-25 | 中国科学院合肥物质科学研究院 | Method for enhancing Raman signals with nano super-crystal technology to identify microorganisms |
CN105067524A (en) * | 2015-08-12 | 2015-11-18 | 苏州大学 | Micro device for enhancing fluorescence of fluorescent molecules |
CN106124476A (en) * | 2016-06-21 | 2016-11-16 | 中山大学 | Based on surface enhanced raman spectroscopy and the glucose sensing approach of bi-molecular probe |
CN109001176A (en) * | 2018-06-14 | 2018-12-14 | 福建师范大学 | A kind of preparation method of the SERS substrate of Au@Ag nanoparticle and method using substrate detection glucose |
-
2019
- 2019-09-11 WO PCT/CN2019/105288 patent/WO2021046741A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140234219A1 (en) * | 2013-02-15 | 2014-08-21 | Panasonic Corporation | Method and Device for Detecting Analytes |
CN103257133A (en) * | 2013-04-18 | 2013-08-21 | 上海交通大学 | Preparation method and application of mercury ion detection probe |
CN104458694A (en) * | 2014-11-28 | 2015-03-25 | 中国科学院合肥物质科学研究院 | Method for enhancing Raman signals with nano super-crystal technology to identify microorganisms |
CN105067524A (en) * | 2015-08-12 | 2015-11-18 | 苏州大学 | Micro device for enhancing fluorescence of fluorescent molecules |
CN106124476A (en) * | 2016-06-21 | 2016-11-16 | 中山大学 | Based on surface enhanced raman spectroscopy and the glucose sensing approach of bi-molecular probe |
CN109001176A (en) * | 2018-06-14 | 2018-12-14 | 福建师范大学 | A kind of preparation method of the SERS substrate of Au@Ag nanoparticle and method using substrate detection glucose |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110618123B (en) | Efficient surface-enhanced Raman scattering substrate material and preparation method thereof | |
Damborska et al. | Nanomaterial-based biosensors for detection of prostate specific antigen | |
Wang et al. | Gold nanorod-based localized surface plasmon resonance biosensor for sensitive detection of hepatitis B virus in buffer, blood serum and plasma | |
Truong et al. | A new method for non-labeling attomolar detection of diseases based on an individual gold nanorod immunosensor | |
Chen et al. | Self-assembled colloidal gold superparticles to enhance the sensitivity of lateral flow immunoassays with sandwich format | |
Sokolov et al. | Enhancement of molecular fluorescence near the surface of colloidal metal films | |
Pham et al. | Enzyme-amplified SERS immunoassay with Ag-Au bimetallic SERS hot spots | |
Kairdolf et al. | Minimizing nonspecific cellular binding of quantum dots with hydroxyl-derivatized surface coatings | |
Xie et al. | Nanoscale control of Ag nanostructures for plasmonic fluorescence enhancement of near-infrared dyes | |
Aslan et al. | Metal-enhanced fluorescence from gold surfaces: angular dependent emission | |
Huang et al. | Nanospherical brush as catalase container for enhancing the detection sensitivity of competitive plasmonic ELISA | |
Song et al. | Combination assay of lung cancer associated serum markers using surface-enhanced Raman spectroscopy | |
Wang et al. | Simple synthesis of silver nanoparticles functionalized cuprous oxide nanowires nanocomposites and its application in electrochemical immunosensor | |
Li et al. | A SERS nano-tag-based fiber-optic strategy for in situ immunoassay in unprocessed whole blood | |
TWI691716B (en) | Signal amplification in plasmonic specific-binding partner assays | |
Wu et al. | Gold nanostar-enhanced surface plasmon resonance biosensor based on carboxyl-functionalized graphene oxide | |
Xing et al. | Specific detection of carcinoembryonic antigen based on fluorescence quenching of hollow porous gold nanoshells with roughened surface | |
Tu et al. | Introduction of multilayered magnetic core–dual shell SERS tags into lateral flow immunoassay: A highly stable and sensitive method for the simultaneous detection of multiple veterinary drugs in complex samples | |
JP6602202B2 (en) | Encapsulated dye-coated noble metal nanoparticles with increased surface-enhanced Raman scattering properties as contrast agents | |
Quynh et al. | Development of Fe3O4/Ag core/shell-based multifunctional immunomagnetic nanoparticles for isolation and detection of CD34+ stem cells | |
Wang et al. | Detection of IL-8 in human serum using surface-enhanced Raman scattering coupled with highly-branched gold nanoparticles and gold nanocages | |
Wang et al. | Dual-functional Fe3O4@ SiO2@ Ag triple core-shell microparticles as an effective SERS platform for adipokines detection | |
Qi et al. | One-step homogeneous non-stripping chemiluminescence metal immunoassay based on catalytic activity of gold nanoparticles | |
García‐Rubio et al. | An optical-based biosensor of the epithelial sodium channel as a tool for diagnosing hypertension | |
Panikkanvalappil et al. | Gold-nanoparticle-decorated hybrid mesoflowers: an efficient surface-enhanced Raman scattering substrate for ultra-trace detection of prostate specific antigen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19944827 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19944827 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19944827 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 23/01/2023) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19944827 Country of ref document: EP Kind code of ref document: A1 |